Posts about "healthcare"

A recent study reveals the significant impact of government-funded research on the pharmaceutical industry, with over half of all drugs approved since the beginning of the century linked to federally backed studies.

New research from the Massachusetts Institute of Technology has identified molecules in mucus that can effectively block Salmonella infections. The breakthrough holds promise for developing synthetic versions that could potentially treat or prevent foodborne illnesses.

Vocca, a startup focusing on voice AI technology, has raised .5 million in seed funding to revolutionize phone line management in the healthcare sector. This investment aims to alleviate the burden on medical practices by enhancing communication efficiency.

A comprehensive study involving 3.5 million cells from over 100 human brains has revealed that Alzheimer’s disease progression is significantly tied to the stability of epigenomic structures within the brain. Maintaining this stability could hold the key to resilience against the disease, providing new insights into potential treatment pathways.

Scientists at MIT have developed 'bottlebrush' nanoparticles that can deliver large doses of chemotherapy drugs directly to cancer cells, potentially reducing treatment side effects. These specialized particles are engineered with antibodies that guide them precisely to tumor sites, heralding a new era in targeted cancer therapies.

Ortivity, a pioneering company in orthopedic healthcare, has secured a substantial €200 million investment to expand its innovative clinics across Europe. This investment is part of a broader trend of substantial tech funding deals throughout the continent, reflecting Europe's growing status as a global leader in technical innovation.

Leveraging advanced generative AI techniques, researchers have made promising strides in the design of novel antibiotics capable of combating drug-resistant bacteria like MRSA.

MIT scientists unveil VaxSeer, a cutting-edge AI tool that enhances the selection of flu vaccine strains by predicting virus evolution and antigenicity. This innovation aims to significantly improve the efficacy of vaccines and reduce dependence on traditional guessing methods.